5-methylcytosine has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, A; Bisht, D; Sachan, M | 1 |
| Li, PL; Wang, TZ; Zhang, LY; Zhang, XC | 1 |
1 review(s) available for 5-methylcytosine and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Role of DNA De-methylation intermediate '5-hydroxymethylcytosine' in ovarian cancer management: A comprehensive review.
Topics: 5-Methylcytosine; Carcinoma, Ovarian Epithelial; DNA; DNA Methylation; Epigenesis, Genetic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2022 |
1 other study(ies) available for 5-methylcytosine and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins; Survival Analysis | 2015 |